ArticleJCO precision oncology2023

Beta-Blocker Use Is Associated With Worse Relapse-Free Survival in Patients With Head and Neck Cancer.

Hannah Y Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.